Economical aspect and possible barriers: Clinical perspectiveWritten by Karin Berger
Karin Berger, MBA is Principal RWE Solutions & HEOR at IMS Health with a particular focus on real-world evidence, patient- reported outcomes, and cost-effectiveness evaluation analyses at a national and international level. Formerly Managing Director of MERG (Medical Economics Research Group), an independent German organization providing health economics services to the pharmaceutical industry, university hospitals and European Commission, Karin has more than 14 years experience in the health economics arena. She lectures at several universities, has published extensively in peer-reviewed journals, and regularly presents at economic and medical conferences around the world. Karin graduated as Diplom-Kaufmann (German MBA equivalent) from the Bayreuth University, Germany, with a special focus on health economics.